Executive Summary
Concise statement of the update’s purpose, effective date, and whether the valuation conclusion changed materially.
A precise Financial Valuation Update reduces uncertainty for stakeholders by documenting changed assumptions, refreshed data, and revised conclusions; it supports compliance with reporting and tax rules and helps limit disputes over valuation adjustments.
Identifying responsibilities and circulation lists in the update reduces rework and clarifies who signs and attests to the revised conclusions.
| Field | Configuration |
|---|---|
| Author | Upload and lock original report reference |
| Reviewer | Assign sequential reviewer with comment permissions |
| Approver | Require signature and date on final page |
| Distribution | Auto-send PDF and certificate to listed recipients |
Ensure the chosen provider supports required compliance (for example HIPAA BAA for healthcare or 21 CFR Part 11 for FDA-regulated records) and preserves an immutable audit trail.
Concise statement of the update’s purpose, effective date, and whether the valuation conclusion changed materially.
List financial statements, agreements, market data, and the date ranges used; attach or reference primary documents.
Describe any change in valuation approach, model adjustments, or added discounts/premiums since the prior report.
Present revised cash flows, discount rates, multipliers, and sensitivity tables with clear assumptions.
Discuss material financial, tax, covenant, or reporting effects resulting from the update.
State limitations, reliance restrictions, and any unresolved data gaps or subsequent events.
Allow 5–10 business days for model updates and peer review
Align with auditor schedules, typically before financial statement sign-off
Coordinate to meet tax reporting deadlines affected by valuation changes (e.g., 3 years retention)
Submit within contractually specified windows to avoid covenant breach
File by agency deadlines when updates affect required disclosures
| Document Type | Purpose | Typical Detail |
|---|---|---|
| Full Valuation | comprehensive report | extensive models and disclosures |
| Valuation Update | revise prior conclusions | targeted recalculation and commentary |
| Accounting Memo | support journal entries | focused on standards and adjustments |
| Deal Memorandum | transaction focus | negotiation-oriented summary |
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day free trial | Varies by vendor | Varies by vendor | Varies by vendor | Varies by vendor |
| Bulk Send | Yes | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | No | No |
The individual or firm that performed the update should sign to attest to methodology and assumptions. Their credentials and licensing information should accompany the signature to support reliance.
A named corporate officer or authorized representative signs to accept the update for financial reporting and to acknowledge internal review and distribution responsibilities.
A lender requested a mid-year value check to confirm collateral levels
During due diligence, buyers asked for updated forecasts after a market shift